Clinical and molecular characterization of a multi-institutional cohort of pediatric spinal cord low-grade gliomas.
Sydney T GrobLiana NobreKristen R CampbellKurtis D DaviesScott RyallDara L AisnerLindsey HoffmanShadi ZahediAndrew MorinMichele CrespoAnandani NellanAdam L GreenNicholas ForemanRajeev VibhakarTodd C HankinsonMichael H HandlerCynthia HawkinsUri TaboriB K Kleinschmidt-DeMastersJean M Mulcahy LevyPublished in: Neuro-oncology advances (2020)
KIAA1549-BRAF was seen in higher frequency than BRAF V600E or other genetic aberrations in pediatric spinal LGGs and experienced lower death rates compared to KIAA1549-BRAF negative patients, although this was not statistically significant.